Novel antibacterial oxazolidinones bearing pyrrolidinone ring system at the C-5 side chain were synthesized and their in vitro antibacterial activities were evaluated. Most of the synthesized oxazolidinones showed good antibacterial activity against the Gram-positive and Gram-negative bacteria tested.
Introduction
Because of deficiency in innovative advance in the antibacterial drug development, the increasing incidence and prevalence of bacterial resistance to clinically useful antibiotics is one of the most serious global health threats of the last two decades. [1] [2] [3] [4] Oxazolidinones are a new class of antibacterial agents used to overcome the innovation deficiency. Linezolid (Figure 1 ) is the first oxazolidinone antibiotics approved in 2000 for the treatment of Gram-positive bacterial infections in humans. 5 It exhibits consistent activity against multi-resistant gram-positive pathogens including methicillinresistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE) and penicillin-resistant Streptococcus pneumouniae. 6, 7 Furthermore, oxazolidinone class antibiotics show good activity against multidrug resistance Mycobacterium tuberculosis infections which is one of the most threatening and wide spreading infectious disease. [8] [9] [10] Linezolid is known to inhibit bacterial protein synthesis by binding to 50S ribosomal subunit at the translation step and prevent the formation of 70S complex, and the binding mode was confirmed by X-ray crystallography.
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Linezolid is widely used in clinical care as a synthetic unnatural antibiotics and is now prescribed as a last resort antibiotics for the treatment of multi-resistant pathogens like vancomycin, however, clinical emergences of linezolid resistant bacteria including Staphylococci and Enterococci have been reported. [12] [13] [14] The most common mechanism of linezolid resistance is point mutations in the 23S rRNA peptidyl transferase region, [15] [16] [17] [18] and recently a new resistance mechanism mediated by cfr gene encoding methyltransferase has been reported. 19, 20 Thus, there is a significant need for the development of new oxazolidinone series with an improved potency and spectrum of antibacterial activity.
Four types of chemical modifications of linezolid and oxazolidinone-type antibiotics have been reported, [21] [22] [23] [24] including modifications on each of the A, B and C-rings as well as the C-5 side chain of the A-ring substructure.
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Among them, recently, torezolid 25 and radezolid 27 as shown in Figure 1 are under clinical development.
Oxazolidinones containing a lactam substituent represented not only antibacterial agents 28, 29 but also antithrombotic agents. Rivaroxaban, a lactam substituted oxazolidinone marketed as Xarelto, is orally active and highly potent coagulation factor Xa inhibitors and has been approved in United States recently for the prophylaxis of venous thromboembolism (VTE).
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Herein we report the synthesis and biological evaluation of a series of oxazolidinone-type antibiotics in which the Cring has been modified by substituted pyrrolidinone ring as shown in Figure 2 . Both acetamide and triazole are used as a C-5 side chain. The resulting compounds were then screened against Gram-positive, Gram-negative bacteria, and also Mycobacterium tuberculosis (Mtb) H 37 Rv.
Experimental Section
General.
1

H and
13
C-NMR spectra were recorded on Bruker DPX 300 MHz spectrophotometer using CDCl 3 , CD 3 OD, DMSO-d 6 as NMR solvent. TMS was used as an internal standard and chemical shift data are reported in parts per million (ppm) and s, d, t, and m are designated as singlet, doublet, triplet and multiplet respectively. Coupling constants (J) were reported in hertz (Hz). Mass spectra were recorded on Waters Acquity UPLC/Synapt G2 QTOF MS mass spectrometer. The reaction progress was monitored by thin layer chromatography (TLC).
(S)-N-(4-(5-(Acetamidomethyl)-2-oxo-oxazolidin-3-yl)-2-fluorophenyl)-4-chlorobutanamide (2a). Sodium carbonate (87 mg, 0.89 mmol) was added to the solution of aniline 1a (20 mg, 0.74 mmol) in acetone at room temperature. 4-Chlorobutyryl chloride (0.10 mL, 0.89 mmol) was added to the mixture slowly. Reaction mixture was stirred at the same temperature for 5 h and concentrated. Water (5 mL) was added and the mixture was extracted with CH 2 Cl 2 (10 mL × 2). The combined organic layers were dried over MgSO 4 and concentrated under reduced pressure. The residue was purified by flash chromatography on silica gel (hexane/EtOAc, 10:1) to yield amide 2a (24 mg, 86%): (S)-N-((3-(3-Fluoro-4-(2-oxo-pyrrolidin-1-yl)phenyl)-2-oxo-oxazolidin-5-yl)methyl)acetamide (3a). Amide 2a (200 mg, 0.54 mmol) was dissolved in ethanol (5 mL) and potassium hydroxide (45.4 mg, 0.81 mmol) was added. Reaction mixture was stirred at room temperature for 3 h. Solvent was concentrated, and the mixture was extracted with chloroform (10 mL × 2). The combined organic layers were washed with brine, dried over MgSO 4 and concentrated under reduced pressure. 
Compound 6a (3.7 g, 8.3 mmol) and triphenyl phosphine (2.6 g, 9.8 mmol) were dissolved in CH 2 Cl 2 (100 mL) and diethyl azodicarboxylate (1.7 g, 9.8 mmol) was added slowly for 20 min at ice bath temperature. The reaction mixture was stirred at room temperature for 4 h. Water (20 mL) was added and the mixture was extracted with CH 2 Cl 2 (100 mL × 2). The combined organic layers were dried over MgSO 4 and concentrated under reduced pressure. The residue was purified by flash chromatography on silica gel (CH 2 Cl 2 /MeOH, 25:1) to yield lactam 7a (2.98 g, 84%): 
Benzyl ether 7a (1.0 g, 2.26 mmol) was dissolved in ethyl alcohol (50 mL), and palladium hydroxide in activated charcoal (0.16 g, 5 mol %) and cyclohexene (10 mL) were added. Reaction mixture was refluxed for 3 d, cooled to room temperature and filtered through celite. The filtrate was concentrated and the residue was purified by flash chromatography on silica gel (CH 2 Cl 2 /MeOH, 10:1) to yield alcohol 8a (0.73 g, 92%): 
Thionyl chloride (60 µL) was added dropwise to a solution of alcohol 8a (120 mg, 0.34 mmol) in acetonitrile (8 mL) at room temperature. The reaction mixture was refluxed for 24 h, cooled to room temperature and concentrated under reduced pressure. The residue was purified by flash chromatography on silica gel (CH 2 Cl 2 /MeOH, 10:1) to yield chloride 10b (70.6 mg, 56%): 0 (s, 3H) . 
N-(((S)-3-(3-Fluoro-4-((S)-4-hydroxy-2-oxo-pyrrolidin-1-yl)phenyl)-2-oxo-oxazolidin-5-yl)methyl)acetamide (19a).
Compound 19a was prepared 18a according to the similar procedure for the preparation of compound 8a (yield 73%): 
Results and Discussion
Chemistry. Two types of oxazolidinone starting material, acetamide 1a and 1,2,3-triazole 1b, were synthesized by modification of literature method. 33, 34 Oxazolidinone derivatives having pyrrolidinone at the C-ring were prepared by coupling of amino group in 1a and 1b with 4-chlorobutyryl chloride and the subsequent cyclization to form pyrrolidone in good yields as shown in Scheme 1.
α-Hydroxy pyrrolidinonyl oxazolidinone 8a and 8b were also prepared by the condensation of amino group in 1a and 1b with 3-(benzyloxy)dihydrofuran-2(3H)-one and followed by intramolecular Mitsunobu-type cyclization and subsequent hydrogenation protocol as shown in Scheme 2. α-Hydroxy pyrrolidinone 8a was obtained as inseparable diastereomeric mixture, and one of its single diastereomer was prepared by using optically active 3(R)-3-(benzyloxy)dihydrofuran-2(3H)-one. The synthesis of other oxazolidinone derivatives having α-substituted pyrrolidinones at C-ring of linezolid was shown in Scheme 2 too. Halogenation of alcohol 8a and 8b gave the fluoride, chloride and bromide compounds 9-11 by using diethylaminosulfur trifluoride (DAST), thionyl chloride and triphenylphosphine with carbon tetrabromide respectively in moderate to good yields. O-Methylation of α-hydroxy compound 8a with methyl iodide in the presence of silver oxide provided α-methoxy compound 12a.
N-Aryl-2-oxo-pyrrolidine-3-carboxylic acid 14a were synthesized by the reaction of arylamine 1a and 6,6-dimethyl-5,7-dioxaspiro[2.5]octane-4,8-dione 13 in toluene at Scheme 1. i) Na2CO3, acetone, rt, 5 h, 86% (2a), 85% (2b); ii) KOH, EtOH, rt, 3 h, 63% (3a), 68% (3b).
reflux condition in good yield as shown in Scheme 3.
3-Substituted-2-oxo-pyrrolidinyl oxazolidinone derivatives 18-23 were synthesized from 4-hydroxydihydrofuran-2(3H)-one 15 following the similar synthetic procedure of the corresponding α-substituted compounds 7-12 as shown in Scheme 4.
Biological Evaluation. This series of oxazolidinone antimicrobial compounds prepared above were screened against panel of susceptible and resistance bacteria. MICs (µg/mL) of these compounds against standard strains were summarized in Table 1 and linezolid was used as a reference compound for comparison. The compounds were also tested against drug-resistant strains such as MRSA, VRE (vancomycinresistant Enterococcus faecium), Coagulase negative Staphylococi, E. faecalis, and S. pneumonia, and the results were shown in Table 2 .
Most of the prepared oxazolidinone derivatives having pyrrolidinone moiety exhibited good activity against the tested Gram-positive and Gram-negative bacteria (Table 1 and Table 2 ). The new pyrrolidone compounds bearing acetamide at position C-5 were more active than those with 1,2,3-triazole at the same position, and the α-substituted pyrrolidinone compounds were more active than the corresponding α-substituted compounds.
Among C-5 acetamide-substituted oxazolidinones, pyrrolidinone compound 3a had comparable activity with the reference compound linezolid but α-hydroxy substituted pyrrolidinone compound 8a lost the activity. In case of 8a, both single isomer and diastereomeric mixture exhibited similar antibacterial activity against most tested strains. However oxazolidinones with halogenated pyrrolidinone moiety at α-or β-position (9a-11a, 20a-22a) showed com- parable antibacterial activities against most tested bacteria including resistant strains with the linezolid. Substitution of methoxy and carboxylic group at α-position of pyrrolidone (12a, 14a) lost the activity slightly, and β-hydroxy compounds 19a completely lost the activity.
Among C-5 1,2,3-triazole oxazolidinones, pyrrolidinone compound 3b was less active than reference compound, and substitution of hydroxyl group at α-position of pyrrolidinone (8b) slightly improved the activity. Fluoride and chloride substituted oxazolidinones at α-position of pyrrolidone (9b and 10b) showed good antibacterial activity, and demonstrated similar activities against most resistant strains compared to linezolid. Almost β-substituted compounds at pyrrolidinone part were less active than α-substituted compounds in the 1,2,3-triazole series, and β-hydroxy compound 19b completely lost the activity. The 2-oxopyrrolidinyl oxazolidinones of both C-5 acetamide and triazole series are less active than linezolid against gram-negative Hameophilus influenza.
Notably, the new oxazolidinone derivatives possessing pyrrolidinone moiety showed comparable or higher activity than linezolid against Mycobacterium tuberculosis (Mtb) H 37 Rv as shown in Table 2 . Compound 11a, 20a and 9b showed 2-fold higher activity than linezolid against Mycobacterium tuberculosis.
Conclusion
A new series of oxazolidinones having 2-oxopyrrolidine moiety have been synthesized, and their in vitro antibacterial activities were evaluated against Gram-positive, Gramnegative bacteria including resistant strains of Staphylococi, Streptococci and Enterococci. Some of these analogs exhibited potent in vitro antibacterial activities comparable or superior to linezolid. The compounds exhibited potent antibacterial activity against Mycobacterium tuberculosis (Mtb) H37Rv, and the compound 11a, 20a and 9b showed 2-fold higher activity than linezolid against M. tuberculosis. 
